Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial

Preclinical data suggest that the anti-tumour activity of capecitabine is enhanced by taxanes and mitomycin C through up-regulation of thymidine phosphorylase (TP). Here, we studied safety and efficacy of the combination of capecitabine with docetaxel and mitomycin C. Two dose levels (DL) were inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Ernst, T, Merx, K, Gnad-Vogt, U, Lukan, N, Kripp, M, Schultheis, B, Hochhaus, A, Hofheinz, R-D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360249/
https://www.ncbi.nlm.nih.gov/pubmed/18000507
http://dx.doi.org/10.1038/sj.bjc.6604067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360249/
https://www.ncbi.nlm.nih.gov/pubmed/18000507
http://dx.doi.org/10.1038/sj.bjc.6604067

Ejemplares similares